Hiv vaccine peptide

Peptide-based HIV vaccines use synthetic peptides, often derived from vulnerable sites on the virus’s surface like the fusion peptide (FP) of the Env glycoprotein, to elicit broadly neutralizing antibodies and guide the immune response. These peptides are typically coupled to carrier proteins, including KLH, to boost their immunogenicity by providing T cell help, that is often lacking in short peptides. The goal is to train the immune system to neutralize diverse HIV strains, moving beyond current therapeutic approaches toward a preventive HIV vaccine. The directory classifies it as a under development API with a peptide source/manufacturing origin. Other names for this substance include NSC732084, E1M184V peptide and HIV vaccine peptide. Its PubChem CID is 24204505.

Molecular Formula C52H76N10O17
Molecular Weight 1113.2 g/mol
Synonyms 2-[[2-[[2-[[2-[[2-[[5-amino-2-[[2-[[2-[(2-amino-3-methylbutanoyl)amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid

Frequently Asked Questions